ADAMTS20
A disintegrin and metalloproteinase with thrombospondin motifs 20
Also known as: ATS20_HUMAN, GON-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P59510
- Gene
- ADAMTS20
- Ensembl
- ENSG00000173157
- Chromosome
- 12
- Canonical length
- 1910 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus,Microtubules,Mitotic spindle,Primary cilium,Basal body,Cytosol
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
The protein encoded by this gene is a member of the ADAMTS family of zinc-dependent proteases. The encoded protein has a signal peptide that is cleaved to release the mature peptide, which is secreted and found in the extracellular matrix. This protein may be involved in tissue remodeling. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
1910 residues, UniProt reviewed canonical sequence.
>P59510|ADAMTS20
1 MWVAKWLTGL LYHLSLFITR SWEVDFHPRQ EALVRTLTSY EVVIPERVNE FGEVFPQSHH
61 FSRQKRSSEA LEPMPFRTHY RFTAYGQLFQ LNLTADASFL AAGYTEVHLG TPERGAWESD
121 AGPSDLRHCF YRGQVNSQED YKAVVSLCGG LTGTFKGQNG EYFLEPIMKA DGNEYEDGHN
181 KPHLIYRQDL NNSFLQTLKY CSVSESQIKE TSLPFHTYSN MNEDLNVMKE RVLGHTSKNV
241 PLKDERRHSR KKRLISYPRY IEIMVTADAK VVSAHGSNLQ NYILTLMSIV ATIYKDPSIG
301 NLIHIVVVKL VMIHREEEGP VINFDGATTL KNFCSWQQTQ NDLDDVHPSH HDTAVLITRE
361 DICSSKEKCN MLGLSYLGTI CDPLQSCFIN EEKGLISAFT IAHELGHTLG VQHDDNPRCK
421 EMKVTKYHVM APALSFHMSP WSWSNCSRKY VTEFLDTGYG ECLLDKPDEE IYNLPSELPG
481 SRYDGNKQCE LAFGPGSQMC PHINICMHLW CTSTEKLHKG CFTQHVPPAD GTDCGPGMHC
541 RHGLCVNKET ETRPVNGEWG PWEPYSSCSR TCGGGIESAT RRCNRPEPRN GGNYCVGRRM
601 KFRSCNTDSC PKGTQDFREK QCSDFNGKHL DISGIPSNVR WLPRYSGIGT KDRCKLYCQV
661 AGTNYFYLLK DMVEDGTPCG TETHDICVQG QCMAAGCDHV LNSSAKIDKC GVCGGDNSSC
721 KTITGVFNSS HYGYNVVVKI PAGATNVDIR QYSYSGQPDD SYLALSDAEG NFLFNGNFLL
781 STSKKEINVQ GTRTVIEYSG SNNAVERINS TNRQEKEILI EVLCVGNLYN PDVHYSFNIP
841 LEERSDMFTW DPYGPWEGCT KMCQGLQRRN ITCIHKSDHS VVSDKECDHL PLPSFVTQSC
901 NTDCELRWHV IGKSECSSQC GQGYRTLDIH CMKYSIHEGQ TVQVDDHYCG DQLKPPTQEL
961 CHGNCVFTRW HYSEWSQCSR SCGGGERSRE SYCMNNFGHR LADNECQELS RVTRENCNEF
1021 SCPSWAASEW SECLVTCGKG TKQRQVWCQL NVDHLSDGFC NSSTKPESLS PCELHTCASW
1081 QVGPWGPCTT TCGHGYQMRD VKCVNELASA VLEDTECHEA SRPSDRQSCV LTPCSFISKL
1141 ETALLPTVLI KKMAQWRHGS WTPCSVSCGR GTQARYVSCR DALDRIADES YCAHLPRPAE
1201 IWDCFTPCGE WQAGDWSPCS ASCGHGKTTR QVLCMNYHQP IDENYCDPEV RPLMEQECSL
1261 AACPPAHSHF PSSPVQPSYY LSTNLPLTQK LEDNENQVVH PSVRGNQWRT GPWGSCSSSC
1321 SGGLQHRAVV CQDENGQSAS YCDAASKPPE LQQCGPGPCP QWNYGNWGEC SQTCGGGIKS
1381 RLVICQFPNG QILEDHNCEI VNKPPSVIQC HMHACPADVS WHQEPWTSCS ASCGKGRKYR
1441 EVFCIDQFQR KLEDTNCSQV QKPPTHKACR SVRCPSWKAN SWNECSVTCG SGVQQRDVYC
1501 RLKGVGQVVE EMCDQSTRPC SQRRCWSQDC VQHKGMERGR LNCSTSCERK DSHQRMECTD
1561 NQIRQVNEIV YNSSTISLTS KNCRNPPCNY IVVTADSSQC ANNCGFSYRQ RITYCTEIPS
1621 TKKHKLHRLR PIVYQECPVV PSSQVYQCIN SCLHLATWKV GKWSKCSVTC GIGIMKRQVK
1681 CITKHGLSSD LCLNHLKPGA QKKCYANDCK SFTTCKEIQV KNHIRKDGDY YLNIKGRIIK
1741 IYCADMYLEN PKEYLTLVQG EENFSEVYGF RLKNPYQCPF NGSRREDCEC DNGHLAAGYT
1801 VFSKIRIDLT SMQIKTTDLL FSKTIFGNAV PFATAGDCYS AFRCPQGQFS INLSGTGMKI
1861 SSTAKWLTQG SYTSVSIRRS EDGTRFFGKC GGYCGKCLPH MTTGLPIQVILocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADAMTS20 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 0.5 nTPM
Expression across tissuesHPA
Tissue
- placenta: 0.5 nTPM
- retina: 0.5 nTPM
- testis: 0.3 nTPM
- cerebral cortex: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
Single-cell type
- retinal bipolar cells: 85 nCPM
- extravillous trophoblasts: 50 nCPM
- thymic myoid cells: 27 nCPM
- retinal amacrine cells: 13 nCPM
- oligodendrocytes: 11 nCPM
- brain inhibitory neurons: 11 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 6.7 nTPM
- medulla oblongata: 3.6 nTPM
- basal ganglia: 0.6 nTPM
- hypothalamus: 0.6 nTPM
- midbrain: 0.6 nTPM
- cerebral cortex: 0.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.69
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- extracellular matrix organization
- melanocyte differentiation
- negative regulation of apoptotic process
- positive regulation of melanocyte differentiation
- positive regulation of signal transduction
- proteolysis
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Thrombospondin type-1 (TSP1) repeat
- Peptidase M12B, ADAM/reprolysin
- Peptidase M12B, propeptide
- ADAMTS/ADAMTS-like, Spacer 1
- Peptidase M12B, GON-ADAMTSs
- ADAMTS/ADAMTS-like
- Metallopeptidase, catalytic domain superfamily
- Thrombospondin type-1 repeat superfamily
- ADAMTS, cysteine-rich domain 2
- ADAMTS/ADAMTS-like, cysteine-rich domain 3
- ADAMTS and ADAMTS-like
- Thrombospondin type 1 domain
- Reprolysin (M12B) family zinc metalloprotease
- Reprolysin family propeptide
- ADAM-TS Spacer 1
- GON domain
- ADAMTS cysteine-rich domain 2
- Thrombospondin type 1 domain
- ADAMTS cysteine-rich domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADAMTS20 as an antibody target. Whether an autoantibody or antibody against ADAMTS20 could matter depends on whether native ADAMTS20 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADAMTS20 is annotated as secreted, so native ADAMTS20 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ADAMTS20 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...